Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 3 for:    NSR-REP1

Efficacy and Safety of AAV2-REP1 for the Treatment of Choroideremia (STAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03496012
Recruitment Status : Active, not recruiting
First Posted : April 12, 2018
Last Update Posted : February 21, 2020
Sponsor:
Collaborator:
Biogen
Information provided by (Responsible Party):
NightstaRx Ltd, a Biogen Company

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 30, 2020
Estimated Study Completion Date : November 30, 2020